{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:37:01Z","timestamp":1767087421214,"version":"3.48.0"},"reference-count":61,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2025-0146_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Non-alcoholic steatohepatitis (NASH) is a multifactorial chronic liver disease with limited treatment options.\n                      <jats:italic>Murraya koenigii<\/jats:italic>\n                      has reported hepato-protective effects against NASH in humans, but the bioactive compounds and mechanisms remain unknown. In this study, we explored the bioactive compounds of\n                      <jats:italic>M.\u00a0koenigii<\/jats:italic>\n                      and their potential mechanisms for combating NASH using network pharmacology and molecular docking approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0146_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using online platforms such as IMPPAT, GeneCards, KEGG, and DisGeNET, we identified the phytochemicals, target proteins, and genes associated with NASH. Through Venn diagram analysis, we determined 31 common targets between the bioactive compounds and NASH-related genes. Gene ontology (GO) and KEGG pathway enrichment analyses further revealed the key targets and underlying mechanisms. Molecular docking validated the binding interactions between the identified phytochemicals and core target proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0146_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine key targets (NFKB, HSP90, TLR4, ESR1, STAT3, MTOR, HIF1A, PI3KA, and PKCD) were identified that interacts with 16 selected phytochemicals. Molecular docking studies indicated phytochemicals, Osthole and Spathulenol to be the promising binders to the core targets especially NF-kB and STAT3. The results represented the muti-target, multi-compound and multi-pathway mechanisms of\n                      <jats:italic>M.\u00a0koenigii<\/jats:italic>\n                      against NASH.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0146_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study provides the evidence for further research into the mechanisms of\n                      <jats:italic>M.\u00a0koenigii<\/jats:italic>\n                      bioactive compounds as complementary therapies for NASH. Our study also identifies the novel drug candidates based on\n                      <jats:italic>M.\u00a0koenigii<\/jats:italic>\n                      active compounds.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2025-0146","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T18:58:28Z","timestamp":1756148308000},"page":"690-703","source":"Crossref","is-referenced-by-count":0,"title":["Network pharmacology based investigation of the multi target mechanisms of\n                    <i>Murraya koenigii<\/i>\n                    (curry leaves) in non-alcoholic steatohepatitis (NASH)"],"prefix":"10.1515","volume":"22","author":[{"given":"Harsh","family":"Kashyap","sequence":"first","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University , Noida , Uttarpradesh , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science , Shaheed Rajguru College of Applied Sciences for Women, University of Delhi , Delhi , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-2646","authenticated-orcid":false,"given":"Manisha","family":"Khatri","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science , Shaheed Rajguru College of Applied Sciences for Women, University of Delhi , Delhi , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2025123009332449645_j_jcim-2025-0146_ref_001","doi-asserted-by":"crossref","unstructured":"Younossi, ZM, Stepanova, M, Ong, J, Trimble, G, AlQahtani, S, Younossi, I, et al.. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol 2021;19:580\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.064.","DOI":"10.1016\/j.cgh.2020.05.064"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_002","doi-asserted-by":"crossref","unstructured":"Eslam, M, Newsome, PN, Sarin, SK, Anstee, QM, Targher, G, Romero-Gomez, M, et al.. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020;73:202\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039.","DOI":"10.1016\/j.jhep.2020.07.045"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_003","doi-asserted-by":"crossref","unstructured":"Kanwal, F, Shubrook, JH, Younossi, Z, Natarajan, Y, Bugianesi, E, Rinella, ME, et al.. Preparing for the NASH epidemic: a call to action. Gastroenterol 2021;161:1030\u201342e8. https:\/\/doi.org\/10.1053\/j.gastro.2021.04.074.","DOI":"10.1053\/j.gastro.2021.04.074"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_004","doi-asserted-by":"crossref","unstructured":"Chalasani, N, Younossi, Z, Lavine, JE, Charlton, M, Cusi, K, Rinella, M, et al.. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatol 2018;67:328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","DOI":"10.1002\/hep.29367"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_005","doi-asserted-by":"crossref","unstructured":"Parthasarathy, G, Revelo, X, Malhi, H. Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun 2020;4:478\u201392. https:\/\/doi.org\/10.1002\/hep4.1479.","DOI":"10.1002\/hep4.1479"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_006","doi-asserted-by":"crossref","unstructured":"Sheka, AC, Adeyi, O, Thompson, J, Hameed, B, Crawford, PA, Ikramuddin, S. Nonalcoholic steatohepatitis: a review. JAMA 2020;323:1175\u201383. https:\/\/doi.org\/10.1001\/jama.2020.2298.","DOI":"10.1001\/jama.2020.2298"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_007","doi-asserted-by":"crossref","unstructured":"Bugianesi, E, Petta, S. NAFLD\/NASH. J Hepatol 2022;77:549\u201350. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.006.","DOI":"10.1016\/j.jhep.2022.02.006"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_008","doi-asserted-by":"crossref","unstructured":"Lambert, JE, Ramos-Roman, MA, Browning, JD, Parks, EJ. Increased de Novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterol 2014;146:726\u201335. https:\/\/doi.org\/10.1053\/j.gastro.2013.11.049.","DOI":"10.1053\/j.gastro.2013.11.049"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_009","doi-asserted-by":"crossref","unstructured":"Kawano, Y, Cohen, DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 2013;48:434\u201341. https:\/\/doi.org\/10.1007\/s00535-013-0758-5.","DOI":"10.1007\/s00535-013-0758-5"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_010","doi-asserted-by":"crossref","unstructured":"Koyama, Y, Brenner, DA. Liver inflammation and fibrosis. J Clin Invest 2017;127:55\u201364. https:\/\/doi.org\/10.1172\/jci88881.","DOI":"10.1172\/JCI88881"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_011","doi-asserted-by":"crossref","unstructured":"Muthiah, MD, Sanyal, AJ. Current management of non-alcoholic steatohepatitis. Liver Int 2020;40:89\u201395. https:\/\/doi.org\/10.1111\/liv.14355.","DOI":"10.1111\/liv.14355"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_012","doi-asserted-by":"crossref","unstructured":"Harrison, SA, Allen, AM, Dubourg, J, Noureddin, M, Alkhouri, N. Challenges and opportunities in NASH drug development. Nat Med 2023;29:562\u201373. https:\/\/doi.org\/10.1038\/s41591-023-02242-6.","DOI":"10.1038\/s41591-023-02242-6"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_013","doi-asserted-by":"crossref","unstructured":"Friedman, SL, Neuschwander-Tetri, BA, Rinella, M, Sanyal, AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med 2018;24:908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","DOI":"10.1038\/s41591-018-0104-9"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_014","doi-asserted-by":"crossref","unstructured":"Luo, Y, Zeng, Y, Peng, J, Zhang, K, Wag, L, Feng, T, et al.. Phytochemicals for the treatment of metabolic diseases: evidence from clinical studies. Biomed Pharmacother 2023;165:115274. https:\/\/doi.org\/10.1016\/j.biopha.2023.115274.","DOI":"10.1016\/j.biopha.2023.115274"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_015","doi-asserted-by":"crossref","unstructured":"Ahluwalia, V, Sisodia, R, Walia, S, Sati, OP, Kumar, J, Kundu, A. Chemical analysis of essential oils of Eupatorium adenophorum and their antimicrobial, antioxidant and phytotoxic properties. J Pest Sci 2004;2014:341\u20139. https:\/\/doi.org\/10.1007\/s10340-013-0542-6.","DOI":"10.1007\/s10340-013-0542-6"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_016","doi-asserted-by":"crossref","unstructured":"Balakrishnan, R, Vijayraja, D, Jo, SH, Ganesan, P, Su-Kim, I, Choi, DK. Medicinal profile, Phytochemistry, and pharmacological activities of Murraya koenigii and its primary bioactive compounds. Antioxidants 2020;9:101. https:\/\/doi.org\/10.3390\/antiox9020101.","DOI":"10.3390\/antiox9020101"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_017","doi-asserted-by":"crossref","unstructured":"Bhandari, P. Curry leaf (Murraya koenigii) or Cure leaf: review of its curative properties. J Med Nutr Nutraceut 2012;2:92\u20137. https:\/\/doi.org\/10.4103\/2278-019x.101295.","DOI":"10.4103\/2278-019X.101295"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_018","doi-asserted-by":"crossref","unstructured":"Husna, F, Suyatna, FD, Arozal, W, Poerwaningsih, EH. Anti-diabetic potential of Murraya koenigii (L)\u00a0and its antioxidant capacity in nicotinamide-streptozotocin induced diabetic rats. Drug Res 2018;68:631\u20136. https:\/\/doi.org\/10.1055\/a-0620-8210.","DOI":"10.1055\/a-0620-8210"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_019","doi-asserted-by":"crossref","unstructured":"Yeap, SK, Abu, N, Mohamad, NE, Beh, BK, Ho, WY, Ebrahimi, S, et al.. Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice. BMC Compl Altern Med 2015;4:306. https:\/\/doi.org\/10.1186\/s12906-015-0832-z.","DOI":"10.1186\/s12906-015-0832-z"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_020","doi-asserted-by":"crossref","unstructured":"Ningappa, MB, Dhananjaya, BL, Dinesha, R, Harsha, R, Srinivas, L. Potent antibacterial property of APC protein from curry leaves (Murraya koenigii L.). Food Chem 2010;118:747\u201350. https:\/\/doi.org\/10.1016\/j.foodchem.2009.05.059.","DOI":"10.1016\/j.foodchem.2009.05.059"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_021","doi-asserted-by":"crossref","unstructured":"Amna, U, Halimatussakdiah, PW, Saidi, N, Nasution, R. Evaluation of cytotoxic activity from Temurui (Murraya koenigii [Linn.] Spreng) leaf extracts against HeLa cell line using MTT assay. J Adv Pharm Technol Res 2019;10:51\u20135. https:\/\/doi.org\/10.4103\/japtr.japtr-373-18.","DOI":"10.4103\/japtr.JAPTR_373_18"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_022","doi-asserted-by":"crossref","unstructured":"Mahipal, P, Pawar, RS. Nephroprotective effect of Murraya koenigii on cyclophosphamide induced nephrotoxicity in rats. Asian Pac J Trop Med 2017;10:808\u201312. https:\/\/doi.org\/10.1016\/j.apjtm.2017.08.005.","DOI":"10.1016\/j.apjtm.2017.08.005"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_023","doi-asserted-by":"crossref","unstructured":"Shah, P, Singh, SP, Kumar, A. Combined effect of hydroethanolic extracts of Murraya koenigii and Phyllanthus niruri leaves on paracetamol and ethanol-induced toxicity in HepG2 cell line. Curr Sci 2015;109:1320. https:\/\/doi.org\/10.18520\/v109\/i7\/1320-1344.","DOI":"10.18520\/v109\/i7\/1320-1344"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_024","doi-asserted-by":"crossref","unstructured":"Syam, S, Abdul, AB, Sukari, MA, Mohan, S, Abdelwahab, SI, Wah, TS. The growth suppressing effects of girinimbine on hepg2 involve induction of apoptosis and cell cycle arrest. Molecules 2011;16:7155\u201370. https:\/\/doi.org\/10.3390\/molecules16087155.","DOI":"10.3390\/molecules16087155"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_025","doi-asserted-by":"crossref","unstructured":"Nguyen, TK, Phung, HH, Choi, WJ, Ahn, H. Network pharmacology and molecular docking study on the multi-target mechanisms of Aloe vera for Non-Alcoholic Steatohepatitis Treatment. Plants (Basel) 2022;11:3585. https:\/\/doi.org\/10.3390\/plants11243585.","DOI":"10.3390\/plants11243585"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_026","doi-asserted-by":"crossref","unstructured":"Mohanraj, K, Karthikeyan, BS, Vivek-Ananth, RP, Bharath Chand, RP, Aparna, SR, Mangalapandi, P, et al.. IMPPAT: a curated database of Indian medicinal plants, Phytochemistry and therapeutics. Sci Rep 2018;8:4329. https:\/\/doi.org\/10.1038\/s41598-018-22631-z.","DOI":"10.1038\/s41598-018-22631-z"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_027","doi-asserted-by":"crossref","unstructured":"Daina, A, Michielin, O, Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717. https:\/\/doi.org\/10.1038\/srep42717.","DOI":"10.1038\/srep42717"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_028","doi-asserted-by":"crossref","unstructured":"Ru, J, Li, P, Wang, J, Zhou, W, Li, B, Huang, C, et al.. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminf 2014;6:13. https:\/\/doi.org\/10.1186\/1758-2946-6-13.","DOI":"10.1186\/1758-2946-6-13"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_029","unstructured":"Lipinski, CA, Lombardo, F, Dominy, BW, Feeney, PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;3:26."},{"key":"2025123009332449645_j_jcim-2025-0146_ref_030","doi-asserted-by":"crossref","unstructured":"Banerjee, P, Eckert, AO, Schrey, AK, Preissner, R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 2018;46:W257\u201363. https:\/\/doi.org\/10.1093\/nar\/gky318.","DOI":"10.1093\/nar\/gky318"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_031","doi-asserted-by":"crossref","unstructured":"Gallo, K, Goede, A, Preissner, R, Gohlke, BO. SuperPred 3.0: drug classification and target prediction-a machine learning approach. Nucleic Acids Res 2022;50:W726\u201331. https:\/\/doi.org\/10.1093\/nar\/gkac297.","DOI":"10.1093\/nar\/gkac297"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_032","doi-asserted-by":"crossref","unstructured":"Stelzer, G, Rosen, N, Plaschkes, I, Zimmerman, S, Twik, M, Fishilevich, S, et al.. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform 2016;54:30\u20133. https:\/\/doi.org\/10.1002\/cpbi.5.","DOI":"10.1002\/cpbi.5"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_033","doi-asserted-by":"crossref","unstructured":"Sherman, BT, Hao, M, Qiu, J, Jiao, X, Baseler, MW, Lane, HC, et al.. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 2022;50:W216\u201321. https:\/\/doi.org\/10.1093\/nar\/gkac194.","DOI":"10.1093\/nar\/gkac194"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_034","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ero, J, Queralt-Rosinach, N, Bravo, \u00c0, Deu-Pons, J, Bauer-Mehren, A, Baron, M, et al.. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database (Oxf.) 2015:bav028. https:\/\/doi.org\/10.1093\/database\/bav028.","DOI":"10.1093\/database\/bav028"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_035","unstructured":"Oliveros, JC. Venny. An interactive tool for comparing lists with Venn\u2019s diagrams; 2007\u20132015. Available from: https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html."},{"key":"2025123009332449645_j_jcim-2025-0146_ref_036","doi-asserted-by":"crossref","unstructured":"Tang, D, Chen, M, Huang, X, Zhang, G, Zeng, L, Zhang, G, et al.. SRplot: a free online platform for data visualization and graphing. PLoS One 2023;18:e0294236. https:\/\/doi.org\/10.1371\/journal.pone.0294236.","DOI":"10.1371\/journal.pone.0294236"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_037","doi-asserted-by":"crossref","unstructured":"Szklarczyk, D, Gable, AL, Nastou, KC, Lyon, D, Kirsch, R, Pyysalo, S, et al.. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 2021;49:D605\u201312. https:\/\/doi.org\/10.1093\/nar\/gkaa1074.","DOI":"10.1093\/nar\/gkaa1074"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_038","doi-asserted-by":"crossref","unstructured":"Shannon, P, Markiel, A, Ozier, O, Baliga, NS, Wang, JT, Ramage, D, et al.. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","DOI":"10.1101\/gr.1239303"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_039","doi-asserted-by":"crossref","unstructured":"Eberhardt, J, Santos-Martins, D, Tillack, AF, Forli, S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model 2021;61. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203.","DOI":"10.26434\/chemrxiv.14774223.v1"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_040","doi-asserted-by":"crossref","unstructured":"Trott, O, Olson, AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 2010;31:455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.","DOI":"10.1002\/jcc.21334"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_041","doi-asserted-by":"crossref","unstructured":"Goodsell, DS, Zardecki, C, Di Costanzo, L, Duarte, JM, Hudson, BP, Persikova, I, et al.. RCSB Protein Data Bank: enabling biomedical research and drug discovery. Protein Sci 2020;29:52\u201365. https:\/\/doi.org\/10.1002\/pro.3730.","DOI":"10.1002\/pro.3730"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_042","doi-asserted-by":"crossref","unstructured":"Kitchen, DB, Decornez, H, Furr, JR, Bajorath, J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004;3:935\u201349. https:\/\/doi.org\/10.1038\/nrd1549.","DOI":"10.1038\/nrd1549"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_043","doi-asserted-by":"crossref","unstructured":"Leach, AR, Shoichet, BK, Peishoff, CE. Prediction of protein\u2013ligand interactions. Docking and scoring: successes and gaps. J Med Chem 2006;49:5851\u20135. https:\/\/doi.org\/10.1021\/jm060999m.","DOI":"10.1021\/jm060999m"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_044","doi-asserted-by":"crossref","unstructured":"Shaker, B, Tran, KM, Jung, C, Na, D. Introduction of advanced methods for structure-based drug discovery. Curr Bioinf 2021;16:760\u201375. https:\/\/doi.org\/10.2174\/1574893615999200703113200.","DOI":"10.2174\/1574893615999200703113200"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_045","doi-asserted-by":"crossref","unstructured":"Franceschetti, L, Bonomini, F, Rodella, LF, Rezzani, R. Critical role of NF\u03baB in the pathogenesis of non-alcoholic fatty liver disease: a widespread key regulator. Curr Mol Med 2021;21:495\u2013505. https:\/\/doi.org\/10.2174\/1566524020666201026162343.","DOI":"10.2174\/1566524020666201026162343"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_046","doi-asserted-by":"crossref","unstructured":"Luci, C, Bourinet, M, Leclere, PS, Anty, R, Gual, P. Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies. Front Endocrinol 2020;11:597648. https:\/\/doi.org\/10.3389\/fendo.2020.597648.","DOI":"10.3389\/fendo.2020.597648"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_047","doi-asserted-by":"crossref","unstructured":"Adorini, L, Trauner, M. FXR agonists in NASH treatment. J Hepatol 2023;79:1344\u201357. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.034.","DOI":"10.1016\/j.jhep.2023.07.034"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_048","doi-asserted-by":"crossref","unstructured":"Francque, S, Bedossa, P, Ratziu, V, Anstee, QM, Bugianesi, E, Sanyal, AJ, et al.. A randomized controlled trial of the Pan-PPAR agonist lanifibranor in NASH. N Engl J Med 2021;385:1547\u201358. https:\/\/doi.org\/10.1056\/nejmoa2036205.","DOI":"10.1056\/NEJMoa2036205"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_049","doi-asserted-by":"crossref","unstructured":"Harrison, SA, Bashir, MR, Guy, CD, Zhou, R, Moylan, CA, Frias, JP, et al.. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 trial. Lancet 2019;394:2012\u201324. https:\/\/doi.org\/10.1016\/s0140-6736-19-32517-6.","DOI":"10.1016\/S0140-6736(19)32517-6"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_050","doi-asserted-by":"crossref","unstructured":"Ahluwalia, V, Sisodia, R, Walia, S, Sati, OP, Kumar, J, Kundu, A. Chemical analysis of essential oils of Eupatorium adenophorum and their antimicrobial, antioxidant and phytotoxic properties. J Pest Sci 2014;87:341\u20139. https:\/\/doi.org\/10.1007\/s10340-013-0542-6.","DOI":"10.1007\/s10340-013-0542-6"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_051","doi-asserted-by":"crossref","unstructured":"Rautela, R, Das, GK, Khan, FA, Prasad, S, Kumar, A, Prasad, JK, et al.. Antibacterial, anti-inflammatory and antioxidant effects of Aegle marmelos and Murraya koenigii in dairy cows with endometritis. Livest Sci 2018;214:142\u20138. https:\/\/doi.org\/10.1016\/j.livsci.2018.05.015.","DOI":"10.1016\/j.livsci.2018.05.015"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_052","doi-asserted-by":"crossref","unstructured":"Franyoto, YD, Nurrochmad, A, Fakhrudin, N, Murraya koenigii, L, Spreng. An updated review of chemical composition, pharmacological effects, and toxicity studies. J Appl Pharm Sci 2024;14:011\u201327.","DOI":"10.7324\/JAPS.2024.169254"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_053","doi-asserted-by":"crossref","unstructured":"Zheng, Q, Kawaguchi, M, Mikami, H, Diao, P, Zhang, X, Zhang, Z, et al.. Establishment of novel mouse model of dietary NASH rapidly progressing into liver cirrhosis and tumors. Cancers 2023;15:3744. https:\/\/doi.org\/10.3390\/cancers15143744.","DOI":"10.3390\/cancers15143744"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_054","doi-asserted-by":"crossref","unstructured":"Allameh, A, Niayesh-Mehr, R, Aliarab, A, Sebastiani, G, Pantopoulos, K. Oxidative stress in liver pathophysiology and disease. Antioxidants 2023;12:1653. https:\/\/doi.org\/10.3390\/antiox12091653.","DOI":"10.3390\/antiox12091653"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_055","doi-asserted-by":"crossref","unstructured":"Tan, MA, Sharma, N, An, SSA. Multi-target approach of Murraya koenigii leaves in treating neurodegenerative diseases. Pharmaceuticals (Basel) 2022;15:188. https:\/\/doi.org\/10.3390\/ph15020188.","DOI":"10.3390\/ph15020188"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_056","doi-asserted-by":"crossref","unstructured":"Kang, H, Kim, B. Bioactive Compounds as inhibitors of inflammation, oxidative stress and metabolic dysfunctions via regulation of cellular redox balance and histone acetylation State. Foods 2023;12:925. https:\/\/doi.org\/10.3390\/foods12050925.","DOI":"10.3390\/foods12050925"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_057","doi-asserted-by":"crossref","unstructured":"Han, YH, Shin, KO, Kim, JY, Khadka, DB, Kim, HJ, Lee, YM, et al.. A maresin 1\/ROR\u03b1\/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. J Clin Investig 2019;129:1684\u201398. https:\/\/doi.org\/10.1172\/jci124219.","DOI":"10.1172\/JCI124219"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_058","doi-asserted-by":"crossref","unstructured":"Zhao, J, Qi, Y, Yu, Y. STAT3: a key regulator in liver fibrosis. Ann Hepatol 2021;21:100224. https:\/\/doi.org\/10.1016\/j.aohep.2020.06.010.","DOI":"10.1016\/j.aohep.2020.06.010"},{"key":"2025123009332449645_j_jcim-2025-0146_ref_059","unstructured":"Sathaye, S, Amin, P, Mehta, V, Zala, V, Kulkarni, R, Kaur, H, et al.. Immunomodulatory activity of aqueous extract of Murraya Koenigii, L in experimental animals. Int J Toxicol Pharmacol Res 2011;3:7\u201312."},{"key":"2025123009332449645_j_jcim-2025-0146_ref_060","unstructured":"Parimi, BN, Mopuri, R, Meriga, B. The protective effect of Murraya koenigii leaves against carbon tetrachloride-induced hepatic damage in rats. J Coastal Life Med 2014;2:640\u20135."},{"key":"2025123009332449645_j_jcim-2025-0146_ref_061","doi-asserted-by":"crossref","unstructured":"Salwe, KJ, Manimekalai, K. Hepatoprotective and antioxidant activity of Murraya Koenigii leaves extract against paracetamol-induced hepatotoxicity in rats. Int J Basic Clin Pharmacol 2017;6:606\u201310.","DOI":"10.18203\/2319-2003.ijbcp20172044"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0146\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:34:17Z","timestamp":1767087257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0146\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9,19]]},"published-print":{"date-parts":[[2025,12,8]]}},"alternative-id":["10.1515\/jcim-2025-0146"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2025-0146","relation":{},"ISSN":["2194-6329","1553-3840"],"issn-type":[{"type":"print","value":"2194-6329"},{"type":"electronic","value":"1553-3840"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}